Electronic Patient Records to Identify Patients in the United Kingdom with Diabetic Macular Oedema Suitable for ILUVIEN(®) (Fluocinolone Acetonide)

INTRODUCTION: We describe a proactive method using electronic patient records (EPR) to identify pseudophakic patients with diabetic macular oedema (DMO) that might benefit from treatment with 0.2 µg/day fluocinolone acetonide (FAc; ILUVIEN(®)) implant. METHODS: Our EPR audit tool (Medisoft(®)) ident...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ophthalmol Ther
Egile Nagusiak: Butt, Farhat, Khan, Kamron, Chaudhry, Saadia, Khan, Rehna
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer Healthcare 2016
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4909680/
https://ncbi.nlm.nih.gov/pubmed/27192988
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40123-016-0053-7
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak